NYSE:ELN - Elan Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Elan (NYSE:ELN)

Elan logoElan Corporation Ltd (Elan), formerly Elan Corporation, plc, is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. On February 6, 2013, the Company announced that it has entered into an asset purchase agreement with Biogen Idec to transfer to Biogen Idec all Tysabri IP and other assets related to Tysabri. As of 31 December 2012, there were approximately 72,700

Receive ELN News and Ratings via Email

Sign-up to receive the latest news and ratings for ELN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:ELN
CUSIPN/A
Phone+353-1-7094000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Elan (NYSE:ELN) Frequently Asked Questions

What is Elan's stock symbol?

Elan trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELN."

Who are some of Elan's key competitors?

Has Elan been receiving favorable news coverage?

News coverage about ELN stock has been trending somewhat positive this week, according to Accern. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Elan earned a news impact score of 0.22 on Accern's scale. They also assigned news headlines about the biotechnology company an impact score of 47.86 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Elan?

Shares of ELN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Elan?

Elan's mailing address is Treasury Building Grand Canal Street Lower, DUBLIN, 2, Ireland. The biotechnology company can be reached via phone at +353-1-7094000.


MarketBeat Community Rating for Elan (ELN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  152
MarketBeat's community ratings are surveys of what our community members think about Elan and other stocks. Vote "Outperform" if you believe ELN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Elan (NYSE:ELN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/22/2016 forward)

Earnings

Elan (NYSE:ELN) Earnings History and Estimates Chart

Earnings by Quarter for Elan (NYSE:ELN)

Elan (NYSE ELN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2013Q3 2013$0.03($0.03)$56.57 million$48.60 millionViewN/AView Earnings Details
7/24/2013Q213$0.02($0.47)$18.35 million$56.30 millionViewN/AView Earnings Details
4/24/2013Q113$0.05$0.11$0.10 million$0.20 millionViewN/AView Earnings Details
2/6/2013Q412$0.04$0.15$315.45 million$271.00 millionViewN/AView Earnings Details
10/24/2012($0.03)($0.02)ViewN/AView Earnings Details
7/25/2012($0.05)ViewN/AView Earnings Details
4/26/2012$0.04($0.05)ViewN/AView Earnings Details
2/8/2012Q4 2011($0.03)($0.08)ViewN/AView Earnings Details
10/27/2011$0.02$1.15ViewN/AView Earnings Details
7/27/2011($0.02)($0.08)ViewN/AView Earnings Details
4/20/2011($0.03)($0.01)ViewN/AView Earnings Details
2/8/2011($0.04)($0.09)ViewN/AView Earnings Details
10/27/2010Q3 2010($0.03)($0.07)ViewN/AView Earnings Details
7/22/2010Q2 2010($0.05)($0.13)ViewN/AView Earnings Details
10/20/2009Q3 2009($0.14)($0.06)ViewN/AView Earnings Details
7/21/2009Q2 2009($0.16)($0.12)ViewN/AView Earnings Details
4/22/2009Q1 2009($0.12)($0.22)ViewN/AView Earnings Details
2/9/2009Q4 2008($0.11)($0.13)ViewN/AView Earnings Details
10/23/2008Q3 2008($0.13)($0.18)ViewN/AView Earnings Details
7/24/2008Q2 2008($0.13)($0.15)ViewN/AView Earnings Details
4/24/2008Q1 2008($0.15)($0.18)ViewN/AView Earnings Details
2/13/2008Q4 2007($0.14)($0.18)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Elan (NYSE:ELN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Elan (NYSE ELN) Insider Trading and Institutional Ownership History

Insider Trading History for Elan (NYSE:ELN)

Elan (NYSE ELN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Elan (NYSE ELN) News Headlines

Source:

SEC Filings

Elan (NYSE:ELN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Elan (NYSE:ELN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Elan (NYSE ELN) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.